Singapore markets close in 6 hours 57 minutes
Straits Times Index
3,311.96 +19.27 (+0.59%) Nikkei
38,135.95 -138.10 (-0.36%) Hang Seng
17,893.10 +130.07 (+0.73%) FTSE 100
8,121.24 -22.89 (-0.28%) Bitcoin USD
57,161.07 -2,930.30 (-4.88%) CMC Crypto 200
1,254.31 -84.76 (-6.33%)
ABT Nov 2024 105.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:03PM EDT. Market open.
| Previous close | 5.20 |
| Open | 5.25 |
| Bid | 5.15 |
| Ask | 5.30 |
| Strike | 105.00 |
| Expiry date | 2024-11-15 |
| Day's range | 5.10 - 5.25 |
| Contract range | N/A |
| Volume | |
| Open interest | 135 |
ZacksIs Trending Stock Abbott Laboratories (ABT) a Buy Now?
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
ZacksPBH vs. ABT: Which Stock Is the Better Value Option?
PBH vs. ABT: Which Stock Is the Better Value Option?
PR NewswireAbbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.
© 2024 Yahoo. All rights reserved.